The National Pharmaceutical Pricing Authority (NPPA) on Wednesday said it has fixed and revised the ceiling prices of 39 drug formulations.
The move is expected to slash prices of some of these drugs, like Hepatitis B immunoglobulin, by as much as 20%, a senior government told ET on condition of anonymity.
TB drugs like rifabutin, chemotherapy medicines actinomycin D and ifosfamide, migraine medication sumatriptan, measles vaccine and Serum Institute’s anti-rabies drug (rMAb) also figure in NPPA’s latest price control notification.
The latest notification brings the tally of essential medicines under price control to 821 under the National List of Essential Medicines (NLEM), according to a tweet by NPPA.
[Source: http://health.economictimes.indiatimes.com/news/policy/nppa-slashes-prices-of-medicines-for-tb-cancer-hepatitis-b-by-up-to-20/60773017]
PHARMA JAN SAMADHAN
The Pharma Jan Samadhan (PJS) initiative is part of Goverment of India's Digital India initiative, which aims at empowering the citizen through a transparent, accountable and responsive governance system.
The PJS provides the consumer with an effective and time bound grievance redressal system to effectively deal with complaints related to pricing, shortage and non-availability of medicines. Apart from the internet- based online facility, there is a consumer Help Line also, which can be used to lodge complaints. Complaints may also be sent to :-
Member Secretary, NPPA, 3rd Floor, YMCA Cultural Centre Building, 1, Jai Singh Road, New Delhi – 110 001. Tel : 011 – 23746649 Fax : 011 – 23746652 Email : msecy.nppa[at]nic[dot]in HelpLine no. : 011 – 23746647
Online Complain: http://nppaindia.nic.in/cms/complainmain.aspx